These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30638914)

  • 1. Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Lewis DS; Lee TH; Konanur M; Ziegler C; Hall MD; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Choi SS; Ronald J
    J Vasc Interv Radiol; 2019 Feb; 30(2):163-169. PubMed ID: 30638914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
    Dai R; Sag AA; Martin JG; Befera NT; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Muir AJ; Ronald J
    Clin Imaging; 2021 Sep; 77():187-192. PubMed ID: 33940357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Helzberg JH; Dai R; Muir AJ; Wilder J; Lee TH; Martin JG; Kim CY; Ronald J
    J Vasc Interv Radiol; 2021 Jul; 32(7):950-960.e1. PubMed ID: 33663923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Ronald J; Bozdogan E; Zaki IH; Kappus MR; Choi SS; Martin JG; Suhocki PV; Smith TP; Kim CY; Bashir MR
    AJR Am J Roentgenol; 2020 Jan; 214(1):200-205. PubMed ID: 31670594
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.
    Bai M; Qi X; Yang Z; Yin Z; Nie Y; Yuan S; Wu K; Han G; Fan D
    J Gastroenterol Hepatol; 2011 Jun; 26(6):943-51. PubMed ID: 21251067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    Li Y; He X; Pang H
    Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS).
    Sturm L; Bettinger D; Giesler M; Boettler T; Schmidt A; Buettner N; Thimme R; Schultheiss M
    United European Gastroenterol J; 2018 Nov; 6(9):1380-1390. PubMed ID: 30386611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.
    Yin X; Zhang F; Xiao J; Wang Y; He Q; Zhu H; Leng X; Zou X; Zhang M; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1264-1269. PubMed ID: 31136318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
    Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
    J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience.
    Coronado WM; Ju C; Bullen J; Kapoor B
    Cardiovasc Intervent Radiol; 2020 Aug; 43(8):1156-1164. PubMed ID: 32435836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.